The Department of Justice has reportedly launched an investigation into UnitedHealth Group's Medicare billing practices, ...

Amedisys (NASDAQ:AMED) edged lower by 1.2% after a judge tentatively set a date for the Dep. of Justice's challenge of ...

The U.S. Justice Department has launched a probe into UnitedHealth's Medicare billing practices in recent months, the Wall ...

Empowered Funds LLC bought a new stake in Amedisys, Inc. (NASDAQ:AMED – Free Report) during the fourth quarter, Holdings ...

UnitedHealth Group said in a court filing it is working with Amedisys to identify potential buyers for at least 128 home ...

Amid the U.S. Department of Justice’s (DOJ) legal battle with UnitedHealth Group (NYSE: UHG) regarding the planned purchase of Amedisys (Nasdaq: AMED), ...

UnitedHealth Group and Amedisys outlined plans to divest a significant number of home health and hospice locations as they ...

Amedisys (AMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

A trial between the Justice Department and UnitedHealth Group Inc. over its proposed purchase of Amedisys Inc. will take place in October 2025, a Maryland federal judge ruled Thursday.

UnitedHealth Group called The Wall Street Journal's report "misinformation" and said it was unaware of reported investigaiton ...